The purpose of this proposed research is to investigate the sequential cellular events and factors involved in gamma-glutamyltranspeptidase negative (GGT-) hepatocacinogenesis induced in the rat by various hypolipidemic peroxisome proliferators.
The specific aims of this proposal are: 1) to investigate the sequential development of altered areas, neoplastic nodules (NN) and hepatocellular carcinomas (HCC) induced by selected hypolipidemic agents with special emphasis on GGT acitivity; 2) to determine whether the GGT negative phenotype of these various lesions is stable or reversible, i.e. whether GGT can be induced by various manipulations; 3) to determine whether GGT negativity is related to the absence, or to the inactivity of the enzyme; 4) to examine whether Wy-14,643 has any effect on GGT activity in altered areas and NN induced by genotoxic carcinogens; and 5) to evaluate altered areas, NN and HCC for other enzyme alterations such as glucose-6 phosphatase (G6Pase), adenosine triphosphatase (ATPase) and epoxide hydratase (EH), as well as their ability to exclude parenterally administered iron. Comparison of sequential events of GGT negative and GGT positive hepatocarcinogenesis may provide useful information concerning the hepatocarcinogenesis by mutogenic as compared to non-mutogenic carcinogens and factors involved in the expression versus non-expression of GGT.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036130-03
Application #
3173636
Study Section
Pathology B Study Section (PTHB)
Project Start
1984-07-01
Project End
1987-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
School of Medicine & Dentistry
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Rao, M S; Thangada, S; Subbarao, V (1991) Peroxisome proliferation in neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat. Exp Pathol 41:44-9
Bartles, J R; Khuon, S; Lin, X H et al. (1990) Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins. Cancer Res 50:669-76
Rao, M S; Yeldandi, A V; Subbarao, V (1990) Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats. J Toxicol Environ Health 30:85-9
Rao, M S; Reddy, J K (1989) The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis. Drug Metab Rev 21:103-10
Yeldandi, A V; Milano, M; Subbarao, V et al. (1989) Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett 47:21-7
Nemali, M R; Reddy, M K; Usuda, N et al. (1989) Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol Appl Pharmacol 97:72-87
Kasai, H; Okada, Y; Nishimura, S et al. (1989) Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 49:2603-5
Nemali, M R; Usuda, N; Reddy, M K et al. (1988) Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 48:5316-24
Rao, M S; Nemali, M R; Usuda, N et al. (1988) Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res 48:4919-25
Rao, M S; Dwivedi, R S; Subbarao, V et al. (1988) Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound. Br J Cancer 58:46-51

Showing the most recent 10 out of 21 publications